Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 133 500 KRW -1.33% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Gross Margin
Daewoong Pharma

50.6%
Current
49%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
50.6%
=
Gross Profit
708.3B
/
Revenue
1.4T

Gross Margin Across Competitors

Country KR
Market Cap 1.5T KRW
Gross Margin
51%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 364.1B USD
Gross Margin
69%
Country US
Market Cap 248.4B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Daewoong Pharma.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
50.6%
=
Gross Profit
708.3B
/
Revenue
1.4T
What is the Gross Margin of Daewoong Pharma?

Based on Daewoong Pharma's most recent financial statements, the company has Gross Margin of 50.6%.